rss
Br J Ophthalmol 2000;84:1411-1414 doi:10.1136/bjo.84.12.1411
  • Original Article
    • Laboratory science

Mechanism related to reduction of intraocular pressure by melanocortins in rabbits

  1. N Naveha,
  2. A Kaplan-Messasa,
  3. J Marshallb
  1. aGoldschleger Eye Research Institute, Tel Aviv University School of Medicine, Sheba Medical Center, Israel, bRayne's Institute, St Thomas's Hospital, London, UK
  1. Professor N Naveh, 15 Rav Ashi St, Tel Aviv 69395, Israelhnave{at}zahav.net.il
  • Accepted 23 June 2000

Abstract

AIM To investigate whether the ocular hypotensive effect of alpha melanocyte stimulating hormone (MSH) is related to eicosanoids or cyclic AMP (cAMP).

METHODS Intraocular pressure (IOP) readings were taken at a similar time on the day before and after a single dose of topical MSH. Changes in the levels of prostaglandin E2 (PGE2) and prostacyclin in incubated iris ciliary body (ICB) explants were measured by specific radioimmunoassay (RIA). Incubated ICB explants were exposed to MSH or adrenaline (epinephrine) for a week. In addition, cAMP levels in the medium were determined following short term incubation using RIA.

RESULTS A significant dose related reduction in IOP was noted with topical MSH (mean (SD) maximal effect 4.5 (0.1) mm Hg (21%); p<0.001v appropriate baseline) which persisted up to 6 hours (p=0.05). MSH treated ICB explants showed a 1.5-fold increase in PGE2 and prostacyclin levels (p<0.001 for each parameter) while cAMP levels were increased twofold (p<0.001).

CONCLUSIONS A single application of MSH caused a sustained dose related ocular hypotensive effect with no side effects. An increase in eicosanoid and cAMP levels following ICB exposure to MSH indicated their involvement in MSH induced ocular hypotension. MSH and its analogues might have clinical relevance as antiglaucoma drugs with fewer side effects because of their antiallergic and anti-inflammatory properties.

Footnotes

  •  NN and JM have a proprietary interest in the subject.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.